Wall Street Analysts Think Beam Therapeutics (BEAM) Could Surge 84.45%: Read This Before Placing a Bet
Portfolio Pulse from
Wall Street analysts have set an average price target for Beam Therapeutics (BEAM) that suggests a potential upside of 84.5%. This optimistic outlook is supported by positive trends in earnings estimate revisions.
January 28, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Beam Therapeutics (BEAM) is projected to have a potential upside of 84.5% according to Wall Street analysts' average price targets. This is supported by positive trends in earnings estimate revisions.
The article highlights a significant potential upside for BEAM based on analyst price targets and positive earnings estimate revisions. This suggests a bullish sentiment among analysts, which could positively influence the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100